Zyprexa
-
Life after Zyprexa: the Future of Eli Lilly and Company
The Indianapolis pharmaceutical company targets age-related ailments as U.S. patents on some of its most profitable drugs expire.
-
Side Effects
The costly success of Zyprexa, Eli Lilly and Company’s top-selling antipsychotic drug.
Our Latest Stories
-
November 20, 2018
The Feed: King Dough Delivers An Indy Location
-
November 20, 2018
Swoon List: Sakura, Cholita Tacos, And More
-
November 20, 2018
Swoon: Turchetti’s Salumeria
-
November 19, 2018
Review: Anthony’s Chophouse
-
November 19, 2018
Importantville: Buttigieg PAC, Young’s 2020 Map, And Pence In Asia
-
November 16, 2018
Backtrack: Thanksgiving Parade
Upcoming Events
Most Read
